Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stocks, par value $0,0001 per share
-
Shares outstanding
-
58.5M
-
Number of holders
-
39
-
Total 13F shares, excl. options
-
13.2M
-
Shares change
-
-538K
-
Total reported value, excl. options
-
$5.21M
-
Value change
-
-$178K
-
Put/Call ratio
-
0
-
Number of buys
-
13
-
Number of sells
-
-18
-
Price
-
$0.40
Significant Holders of BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB) as of Q2 2025
48 filings reported holding BCAB - BioAtla, Inc. - Common Stocks, par value $0,0001 per share as of Q2 2025.
BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB) has 39 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.2M shares
of 58.5M outstanding shares and own 22.49% of the company stock.
Largest 10 shareholders include ACORN CAPITAL ADVISORS, LLC (4.84M shares), VANGUARD GROUP INC (1.78M shares), ACADIAN ASSET MANAGEMENT LLC (1.49M shares), TANG CAPITAL MANAGEMENT LLC (1.37M shares), RENAISSANCE TECHNOLOGIES LLC (754K shares), DEUTSCHE BANK AG\ (525K shares), GEODE CAPITAL MANAGEMENT, LLC (492K shares), BlackRock, Inc. (481K shares), MORGAN STANLEY (316K shares), and ADAR1 Capital Management, LLC (171K shares).
This table shows the top 39 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.